# A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled Study

> **NCT00517270** · NA · UNKNOWN · sponsor: **Hospital Authority, Hong Kong** · enrollment: 200 (estimated)

## Conditions studied

- Chest Pain

## Interventions

- **DRUG:** Rabeprazole 20mg twice daily

## Key facts

- **NCT ID:** NCT00517270
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2010-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517270, "A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00517270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*